Testing effectiveness (Phase 2)Study completedNCT03765229
What this trial is testing
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 11